Status:
ACTIVE_NOT_RECRUITING
Italian Digital Primary Cardiovascular Prevention Study
Lead Sponsor:
Centro Cardiologico Monzino
Collaborating Sponsors:
Istituto Auxologico Italiano
Humanitas Hospital, Italy
Conditions:
Healthy Population
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reduc...
Detailed Description
CV-PREVITAL is an RCT investigating whether an mHealth application (App) provided on top of usual care, can improve lifestyle habits and CV risk factor control in the short-term, and the incidence of ...
Eligibility Criteria
Inclusion
- Subjects aged ≥ 45 years
- Have given their consent to participate in the study
- Subjects who have a smartphone
Exclusion
- Current or previous cardiovascular disease (personal history of myocardial infarction, angina pectoris, arterial revascularization procedures, stroke, TIA, peripheral artery disease)
- Psychiatric disorders
- Participation in other clinical trials
Key Trial Info
Start Date :
June 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2029
Estimated Enrollment :
27520 Patients enrolled
Trial Details
Trial ID
NCT05339841
Start Date
June 10 2022
End Date
December 1 2029
Last Update
April 4 2025
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Nucleo Cure Primarie Val Pescara
Scafa, Abruzzo, Italy, 65027
2
Progetto Salute Soc. Coop
Martano, Apulia, Italy, 73025
3
Panacea Medical Group
Reggio Calabria, Calabria, Italy, 89132
4
Samnium Medica
Benevento, Campania, Italy, 82018